Relationship Between TSH and Prolactin
Primary hypothyroidism directly causes hyperprolactinemia through compensatory TRH hypersecretion, which simultaneously stimulates both TSH and prolactin release from the anterior pituitary. 1
Physiologic Mechanism
Thyrotropin-releasing hormone (TRH) is the common stimulator that triggers secretion of both TSH and prolactin from the anterior pituitary, creating a direct mechanistic link between these two hormones. 1
When thyroid hormone levels fall in primary hypothyroidism, the hypothalamus increases TRH production to stimulate more TSH. This same TRH elevation simultaneously drives prolactin secretion, explaining why hypothyroid patients develop hyperprolactinemia. 1
Thyroid hormones (T3 and T4) normally inhibit TRH-induced prolactin release. When these hormones are deficient, this inhibitory brake is removed, allowing exaggerated prolactin responses. 2
Clinical Prevalence
Hyperprolactinemia occurs in approximately 43% of women and 40% of men with severe primary hypothyroidism. 1, 3
Even subclinical hypothyroidism is associated with hyperprolactinemia in roughly 36% of women and 32% of men, demonstrating that the TSH-prolactin relationship exists across the spectrum of thyroid dysfunction. 1, 3
Diagnostic Pitfall: The Pseudoprolactinoma
Chronic TRH-driven pituitary hyperplasia in hypothyroidism can mimic a true prolactinoma on imaging, creating a critical diagnostic challenge that requires careful hormonal and radiologic correlation. 1, 3
Pituitary enlargement secondary to hypothyroidism may appear as a mass lesion on MRI, potentially leading to unnecessary dopamine agonist therapy or even surgical referral if TSH is not measured. 1, 4
TSH measurement is essential when evaluating any patient with elevated prolactin to rule out primary hypothyroidism as the underlying cause before assuming a prolactinoma diagnosis. 1, 3, 4
Magnitude of Prolactin Elevation
Prolactin levels in hypothyroidism are typically modest and rarely exceed 100 ng/mL, though exceptional cases with levels above 250 ng/mL have been documented when combined with other factors like macroprolactinemia. 5
When prolactin levels are disproportionately high (>200 ng/mL) in the setting of hypothyroidism, investigate additional etiologies such as macroprolactin or concurrent prolactinoma rather than attributing all elevation to thyroid dysfunction alone. 5
Treatment Response
Thyroid hormone replacement with levothyroxine normalizes both TSH and prolactin levels, resolving pituitary hyperplasia and eliminating the "pseudotumor" appearance on imaging. 4
Resolution of hyperprolactinemia with thyroid hormone replacement confirms that hypothyroidism was the primary driver, avoiding unnecessary treatment with dopamine agonists. 4
Clinical Evaluation Algorithm
When encountering a patient with hyperprolactinemia:
Always measure TSH first to exclude primary hypothyroidism before pursuing prolactinoma workup. 1, 3, 4
If TSH is elevated and prolactin is elevated, treat the hypothyroidism and recheck prolactin after 4-6 weeks of adequate thyroid hormone replacement. 4
If pituitary enlargement is present on imaging with elevated TSH, recognize this as likely pituitary hyperplasia rather than adenoma, and expect resolution with thyroid hormone treatment. 1, 4
For patients with pituitary masses, screen for both prolactin and TSH abnormalities, as stalk compression can disrupt dopaminergic inhibition and elevate both hormones through different mechanisms. 1
Additional Considerations
In pediatric patients with prolactinomas, comprehensive pituitary assessment should include TSH evaluation alongside other anterior pituitary hormones to detect concurrent dysfunction. 1
Severe, prolonged primary hypothyroidism can impair renal and hepatic function, which may independently contribute to hyperprolactinemia, creating a multifactorial picture. 1
Baseline and dynamic pituitary testing can identify concurrent excess or deficiency of other anterior pituitary hormones when hyperprolactinemia is present, ensuring comprehensive endocrine evaluation. 1